THE I~Ulal~OSE OF TI-nS STUDY was to measure some oI the effects of levallorphan on analgesia and respiratory depression produced by meperidine. Of particular interest was the determinalaon of the ratio of meperidine to leval!orphan which, when, they are gwen simultaneously, would provide adequate analgesia without resph-atory depression.
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METHODS ANIJ MAa'Fa~AL
Patients with chronic pain of sufficient severity to require the use of narcotic analgesics served asthe subjects for the experiments. They were not told what drug' they were receiving or what was expected of them. All subjects were given saline, meperidine, and two ratios of meperidine and levaUorphan in successive trials; thus each patient served as his own control and as a basis for comparison. Effects on respiration were measured by testing the response of minute volume to the inhalation of 5 per cent carbon dioxide in oxygen. We believe this to lqe a more sensitive means of judging the reactivity of the respiratory centre than the measuring of respiratory minute volume while the subjects are breathing room air. Respiration was measured on a 18-htre Colhns resplrometer just before the injection of the drug, and 15, g0, 60, and 90 minutes thereafter "whenever this was practicable. The amount of analgesia was evaluated and recorded with the aid of a scale in which 0 indicated no pain; 1, slight pare; 2, moderate pain, and 3, severe pain. Each patient was questioned regardxng the character and degree of pain before and 15 and 80 minutes after the inlection and at 30-mmute intervals thereafter for a total of 4 hours. Accorchngly, dtfferences be[ween the pre-injection pain level and the respectave levels following the injection of the drug gave numbers which were used to inchoate the anaount of pare relief or "analgesia" for each time interval. Thus a difference of 0 meant no pain relief; 1, slight relief; 2, moderate relief, etc. These numbers were added for the entire period of the experiment to ymld a numerical expression of total pain relief. Observations of side reactions were also recorded. The patients were supine throughout the tame of observation. A period of at least 24 hours separated each experiment. All patien~:s were in pain (Grade 2 or 8) at the beginning of each trial. They were not Rermitted to receive a narcotic within 6 hours prior to any observataon period.
The solution of meperidine (Demerol) hydrochloride contained 50 mg/ml. and that of levallorphan (Lorfan) 1 tartrate 1 mg./ml. Half of the patients received injections by the intramuscular route, and the other half by the subcutaneous route. The standard dose of meperidine was 100 mg. for four of the 
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patients and 50 mg. for the other two. The latter were in such poor physical condition that doses higher than 5'0 mg. meperidine were contraindicated. When levallorphan was administered with. meperidine, the two dr, ugs were mixed in the same syringe immediately before injection The ratios by weight of meperidine hydrochlo~ide to levalldrphan tart_rate that were studied Iwere 100:1, 100:1.5 and 50:1. All subjects weregiven meperidine alone and the loo:I.5 mixtures; in addition, three received the 50:1 combination and another three the 100:1 mixture.
RESULTS
The effects of meperidine I alone and of the meperidine-ievallorphan mixtures on the response of respiratqry minute volume to carbon dioxide are shown in Table I figure  obtained for any mixture of meperidine-levallorphan in this study. This patient was in very poor condition on the day of this ]?articular experiment. She had so much upper abdominal pain that her tidal volume was less than 900 ml. The other two patients did at least as well with the 100:1 mixture for the first 80 minutes as they did with the 100:1.5 ratio. We, flaereCore, conclude that a ratio of 100:1 provides protection against respiratory depression. The values at 30 minutes for meperidine alone and the 100:1.5 mixture were submitted to an analysis of variance which is summarized in Table II . The results indicate that while there is no significance to the variance between subject responses, there is statistical significance (P < 0.05) to the varianbe between treatment effects.
The average pain rehef for all treatments is summarized in Table III . These figures represent the average of all the observahons for each period. All the drugs provided signi~cantly greater analgesia t~an did saline. There was no appreciable difference in the analgesia produced by meperidine alone and the combinations with levallorphan. We were somewhat sm'prised at the short duration of meperidine amdgesia in three patients who fated to have further relief of pain 90 minutes after the injection. In one subject (Gqorge A. ), however, analgesia persisted for fore" hours after meperidine alone; and in combination with levallorphan.
Reactions to meperidine and the meperidine-levallorphan mixtures were recorded because it wa,; of interest to, know not ,only which ratio would provide analgesia without respiratory depression, but also which would produce the fewest number of untoward reactions. Table IV provides a summary of these observations. The number of reactions per patient was highest with the 50:1 ratio. There wa, s no significant difference between meperidine alone and the 100:1.5 mixture. The ratio of 100:1 gave the lowest frequency of undesirable reactions. The very low incidence of nausea and the absence of emesis in this series are probably due to the fact that all the patients were in pain at the time the drugs were given and they were recumbent throughout the experiment. The effects of tolerance,would also serw~ to reduce the number of reactions.
DISC'USSION
Hamilton and Cullen (1), in an excellent clinical report on levallorphan, deliberately induced respiratory depression by the intravenous injection of narcotics in anaesthetized patients. They theWgave levallorphan intravenously ~to overcome the depression. In thirty such cases, they used meperidine in doses of 25 to 450 mg. Our analysis of their data indicates that they used ratios of 9_5:1 to 500:1 with an over-all average ratio of 96:1. It would thus appear from their study and our own that a ratio of 100:1 is sufllcient to prevent depression if both drugs are given simultaneously, and to restore respiration when levallorphan is given after the appearance of meperidine-induced depression.
This study demonstrates the wflue of studying drug effects on respiration by using the carbon dioxide technique. The burden that a drug places on the respiratory mechanism may not always be apparent if observations are limited to 876 CANADIAN ANAESTHETISTS' SOCIETY JOURNAL rate, tidal volume, alveolar CO2 and oxygen.,The respiratory system will compensate as best it can in order to maintain homeostasis and, therefore, tests for the adequacy of respiratory exchange reveal only the over-all results. Such tests do not indicate the load or burden upon the respiratory centre. For example, none of our subjects showed any respiratory embarzassment wbfle breathing room air. However, the test with 5 per cent carbon dioxide revealed the depression of the respiratory centre, and uncovered the inability of the system to compensate for this additional stress. Clinically, this may imply a diminution in the patienfs "reserve," and his lack of capacity to eompen.~ate as it relates to respiratory exchange. The clinical significance in anaesthesiology includes the necessity of allowing for this hidden depression whenever narcotic analgesics are used. For example, although the patient who is brought to smgery an hour after being given a narcotic may appear to have good respiratory function, the system is, in fact, already working under a handicap and may be very brittle in its response to inhalation anaesthesia. These same considerations apply in obstetrics when the mother is given a narcotic analgesic within an' hour of delivery. Her respirations may be normal, but the child may have difficulty in overcoming the added burden of a depressed respiratory centre. These factors argue in favour of the use of a combination of narcotic analgesic and antagonist even when respiration appears normal, as a means of increasing the safety factor The clinical usefulness of such combinations has been demonstrated by a number of investigators (2-6).
Although the data from the number of pahents in this study may not lend themselves well to complete statistical analysis (with its mat]hematieal ~xpressions of probability and significance), it cannot easily be denied that there are clinical implications to be derived from very careful observations on a small selected group.
SUMMARy
Meperidine hydrochloride in doses of 50 and 100 mg depresses the respiratory response to 5 per cent carbon dioxide in oxygen. This depression may be observed as early as 15 minutes and as late as 90 minutes after subcutaneous or intramuscular injection.
A mixture of meperidine hydroehloride and levallorphan tartrate in a ratm of 100:1 prevents this depression, does not interfere with analgesia, and does not produce more undesirable reactions than does meperidine itself.
R~SUM~
Le but de cette 6tnde est d'dvaluer quelques-uns des effets du levallorphan sur l'analg4sie et la d6pression xespiratoire produites par la m6pdridine.
Pour r6aliser cette exp6rienee nous avons choisi eomme sujets des malades dont les douleurs ehroniques n6eessitaient l'usage de narcotiques. On a donn6 tousles sujets du s6rum physiologique, de la m6p6ridine et deux doses de On a mesur6 les effet,; sur la respiration en comparant les effets sur le wolume minut6 de l'inhalat~on de 5 _pour cent de gaz carbonique et c_'0xygSne. L'analg6sie a 6t6 appr6ci6e et enreg~str6e ~t l'aide d'une 6chelle off 0 indique aucune douleur; 1, une douleur 16gSre; 2, une douleur mod6r6e; 3, une douleur intense.
Le chlorhydrate de m,6p6ridine ~t la dose de'50 ~ 100 mgm. d6prime la r6ponse de la respiration ~ un m61ange de gaz carbonique de 5 pour cent et d'oxyg~ne. On peut observer cette depressmn "aussi bien 15 mir~utes apr~s 1 m]ectmn souscutan~e ou intramusculaire que 90 minutes apr~s eette injection.
Un m~lange de chlorhydrate de m~p~ridine at de tartxate de levalloqohan dans une proportion de 100 pour 1 fait disparaltre cette d~pression, ne modifie pas l'analg~sie et ne donne pas plus de r~aetlons ind~sirables que ne le fait la m~p~ridine seule.
